catechin has been researched along with Fatty Liver in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (21.43) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (17.86) | 29.6817 |
2010's | 16 (57.14) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Cai, S; Chu, L; Gao, F; Ji, B; Jia, G; Liu, J; Liu, Y; Wang, A; Wei, Y; Wu, W; Xie, L; Zhang, D; Zhou, F | 1 |
Ceballos, G; Hidalgo, I; Meaney, E; Nájera, N; Pérez-Durán, J; Valdespino-Vazquez, Y; Villarreal, F | 1 |
Di Giacomo, M; Ferramosca, A; Zara, V | 1 |
Adamo, AM; Bettaieb, A; Cremonini, E; Daveri, E; Haj, FG; Kalanetra, KM; Karakas, S; Mills, DA; Oteiza, PI; Wang, Z | 1 |
Dai, Z; Feng, S; Huang, J; Liu, A; Lu, W; Reuhl, K; Wang, H; Yang, CS | 1 |
Bae, UJ; Chae, BM; Chae, SW; Jung, SJ; Oh, MR; Park, BH; Park, IW; Park, J; Ryu, GS | 1 |
Chen, W; Hu, D; Ke, H; Li, Y; Su, H; Xie, L; Zheng, X | 1 |
Fung, ML; Ho, CT; Lau, TY; Leung, TM; Liong, EC; Nanji, AA; Tipoe, GL; Xiao, J | 1 |
Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H | 1 |
Bay, BH; Farah, BL; Singh, BK; Sinha, RA; Wu, Y; Yang, CS; Yen, PM; Zhou, J | 1 |
Chakrapani, LN; Durairajan, S; Ganesan, T; J, T; Krishnan, TR; Mangaiah, S; Narasimhan, K; Nathakattur Saravanabavan, S; Periandavan, K; Srinivasan, A; Velusamy, P; Walter, CE | 1 |
Im, JA; Kim, Y; Lee, H; Park, JY | 1 |
Chan, YC; Chang, SJ; Liu, HW; Wang, MF; Wei, CC | 1 |
Carnier, J; de Souza, GH; Lira, FS; Mennitti, LV; Oliveira, JL; Oller do Nascimento, CM; Oyama, LM; Ribeiro, EB; Santamarina, AB; Santana, AA; Silva, FP | 1 |
Bose, M; Ju, J; Lambert, JD; Reuhl, KR; Shapses, SA; Yang, CS | 1 |
Hashimoto, O; Inoue, K; Koga, H; Nakamura, T; Nakayama, H; Otabe, S; Sata, M; Sivakumar, R; Torimura, T; Ueno, T; Yamada, K; Yuan, X | 1 |
Hou, J; Kawai, K; Li, XK; Luo, XY; Sugiyama, T; Takahara, T; Takemoto, M; Takeuchi, M; Tsukada, K; Zhong, L | 1 |
Bruno, RS; Masterjohn, C | 1 |
Aburada, M; Kamiya, T; Kamiya-Sameshima, M; Miyamoto, K; Nagamine, R; Sai, Y; Shimada, T; Takagaki, K; Tokuhara, D; Tsubata, M | 1 |
Bunzendahl, H; Connor, HD; Froh, M; Lemasters, JJ; Lind, H; Mason, RP; Thurman, RG; Zhong, Z | 1 |
Campbell, C; Chavin, KD; Cheng, G; Donovan, JL; Evans, Z; Fiorini, RN; Haines, JK; Markowitz, JS; May, HD; Milliken, CE; Rodwell, D; Schmidt, MG | 1 |
Bahcecioglu, IH; Dagli, AF; Kuzu, N; Ozercan, IH; Sahin, K; Ustündag, B | 1 |
Kovách, G; Salamon, F | 1 |
Beck, P; Boda, Z; Dalmi, L; Misz, M; Pfliegler, G; Weisz, G | 1 |
Meiss, R; Rassat, J; Themann, H | 1 |
Kostova, N; Krŭstev, Z; Lukanov, L; Maleev, A; Tsvetkova, V | 1 |
Gajdos, A; Gajdos-Török, M; Horn, R | 1 |
Gajdos, A; Gajdos-Tërök, M; Horn, R | 1 |
2 review(s) available for catechin and Fatty Liver
Article | Year |
---|---|
Antioxidant dietary approach in treatment of fatty liver: New insights and updates.
Topics: Animals; Anthocyanins; Antioxidants; Carotenoids; Catechin; Coumestrol; Curcumin; Energy Metabolism; Fatty Liver; Glucosinolates; Humans; Imidoesters; Isothiocyanates; Lipogenesis; Mitochondria; Non-alcoholic Fatty Liver Disease; Nutritional Sciences; Oxidative Stress; Oximes; Polyphenols; Quercetin; Resveratrol; Stilbenes; Sulfoxides; Xanthophylls | 2017 |
Therapeutic potential of green tea in nonalcoholic fatty liver disease.
Topics: Catechin; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Extracts; Tea | 2012 |
26 other study(ies) available for catechin and Fatty Liver
Article | Year |
---|---|
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
Topics: Antioxidants; Cell Line; Fatty Liver; Flavonoids; Humans; In Vitro Techniques; Oleic Acid; Reactive Oxygen Species; Triglycerides | 2011 |
Effects of (-)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitis.
Topics: Adiponectin; Animals; Catechin; CD36 Antigens; Cholesterol, LDL; Disease Models, Animal; Fatty Liver; Fructose; Hepatocytes; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Perilipin-2; Perilipin-3; Perilipins; Risk Factors; Triglycerides; Uncoupling Protein 2 | 2020 |
(-)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: Implications for steatosis and insulin resistance.
Topics: Animals; Caco-2 Cells; Catechin; Diet, High-Fat; Fatty Liver; Humans; Insulin Resistance; Intestinal Mucosa; Intestines; Male; Mice, Inbred C57BL; Permeability; Protective Agents | 2018 |
Green Tea Polyphenol EGCG Alleviates Metabolic Abnormality and Fatty Liver by Decreasing Bile Acid and Lipid Absorption in Mice.
Topics: Adipose Tissue; Animals; Bile Acids and Salts; Blood Glucose; Catechin; Fatty Liver; Insulin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Tea | 2018 |
Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway.
Topics: Animals; Catechin; Cell Survival; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Humans; Hyperglycemia; Hypertriglyceridemia; Insulin Resistance; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Obesity; Phytotherapy; Plant Extracts; Sirtuin 1; Tea; Weight Gain | 2018 |
Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Biflavonoids; Catechin; Diet, High-Fat; Fatty Acids, Nonesterified; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Lipogenesis; Liver; Lysosomes; Metabolic Networks and Pathways; Mice; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidation-Reduction; Oxidative Stress; Proanthocyanidins | 2018 |
Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catechin; Cyclooxygenase 2; Diet, High-Fat; Down-Regulation; Fatty Liver; Female; Fibrosis; Forkhead Transcription Factors; Inflammation; Liver; Matrix Metalloproteinase 2; Nerve Tissue Proteins; NF-kappa B; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Tumor Necrosis Factor-alpha | 2014 |
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2014 |
Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance.
Topics: Adenylate Kinase; Animals; Autophagy; Catechin; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Phagosomes; Tea | 2014 |
EGCG mediated downregulation of NF-AT and macrophage infiltration in experimental hepatic steatosis.
Topics: Animals; Antioxidants; Catechin; Cell Adhesion Molecules; Cholesterol, Dietary; Down-Regulation; Drug Evaluation, Preclinical; Fatty Liver; Liver; Macrophages; Male; NF-kappa B; NFATC Transcription Factors; Phytotherapy; Plant Extracts; Rats, Wistar; Tumor Necrosis Factor-alpha | 2014 |
Oligonol suppresses lipid accumulation and improves insulin resistance in a palmitate-induced in HepG2 hepatocytes as a cellular steatosis model.
Topics: Catechin; Fatty Liver; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Models, Biological; Phenols | 2015 |
Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in Senescence-Accelerated Mouse.
Topics: Aging; Animals; Camellia sinensis; Catechin; Dietary Supplements; Fatty Liver; Female; Glucose; Glucose Transporter Type 4; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Muscle, Skeletal; Plant Extracts; Sterol Regulatory Element Binding Protein 1 | 2015 |
Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet.
Topics: AMP-Activated Protein Kinases; Animals; Blotting, Western; Body Weight; Catechin; Diet, High-Fat; Enzyme Activation; Fatty Liver; Male; Mice; Plant Extracts; Protein Serine-Threonine Kinases; Tea | 2015 |
The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.
Topics: Adipose Tissue; Animals; Biomarkers; Body Weight; Catechin; Diet; Dietary Fats; Eating; Fatty Liver; Feces; Lipids; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Tea | 2008 |
Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adipose Tissue; Animals; Catechin; Deoxyguanosine; Fatty Liver; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Mice; Mice, Transgenic; Sterol Regulatory Element Binding Protein 1 | 2009 |
Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model.
Topics: Animals; Antioxidants; Apoptosis; Biflavonoids; Catechin; Cell Line; Cytokines; Fatty Liver; Hepatocytes; Liver Transplantation; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Reperfusion Injury; RNA, Messenger; Tissue Donors; Tumor Necrosis Factor-alpha | 2012 |
Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models.
Topics: Animals; Biflavonoids; Catechin; Diabetes Mellitus; Disease Models, Animal; Fatty Acids; Fatty Liver; Gene Expression Regulation, Enzymologic; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Liver Function Tests; Male; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Oxidation-Reduction; Pinus; Plant Bark; Plant Extracts; Proanthocyanidins; RNA, Messenger; Tomography, X-Ray Computed | 2012 |
Polyphenols from Camellia sinenesis prevent primary graft failure after transplantation of ethanol-induced fatty livers from rats.
Topics: Alanine Transaminase; Aldehydes; Animals; Antioxidants; Bile; Camellia; Catechin; Central Nervous System Depressants; Electron Spin Resonance Spectroscopy; Ethanol; Fatty Liver; Female; Flavonoids; Free Radical Scavengers; Free Radicals; Graft Survival; Liver Transplantation; Necrosis; Phenols; Polyphenols; Rats; Rats, Sprague-Dawley | 2004 |
Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Topics: Animals; Antioxidants; Body Weight; Catechin; Disease Models, Animal; Energy Intake; Energy Metabolism; Fatty Liver; Hepatocytes; Liver; Liver Circulation; Male; Mice; Mice, Obese; Necrosis; Reperfusion Injury | 2005 |
Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
Topics: Animals; Antioxidants; Catechin; Diet; Dietary Fats; Disease Models, Animal; Fatty Liver; Liver; Male; Rats; Rats, Sprague-Dawley | 2008 |
Effects of (+)-cyanidanol-3 on chronic liver injury.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Benzopyrans; Catechin; Chronic Disease; Diabetes Complications; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged | 1984 |
Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
Topics: Adult; Aged; Blood Coagulation Tests; Catechin; Clinical Enzyme Tests; Fatty Liver; Female; Hemostasis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Time Factors | 1984 |
[The effect of (+)-cyanidanol-3 on toxic fatty infiltration of liver parenchyma (author's transl)].
Topics: Animals; Benzopyrans; Catechin; Ethanol; Fatty Liver; Galactosamine; Male; Pentachlorophenol; Polychlorinated Biphenyls; Rats | 1982 |
[Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
Topics: Adult; Aged; Benzopyrans; Catechin; Chronic Disease; Fatty Liver; Female; Hepatitis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1985 |
[Action of (+)-catechin on experimental liver steatosis in the white rat].
Topics: Adenosine Triphosphate; Animals; Catechin; Fatty Liver; Lipid Metabolism; NAD; Oxidoreductases; Rats | 1970 |
The effect of (+)-catechin on the hepatic level of ATP and the lipid content of liver during experimental steatosis.
Topics: Adenosine Triphosphate; Animals; Catechin; Dietary Proteins; Ethanol; Ethionine; Fatty Liver; Female; Flavonoids; Lipid Metabolism; Liver; Malonates; NAD; Orotic Acid; Rats | 1972 |